Brett Jepson

3.3k total citations · 1 hit paper
18 papers, 537 citations indexed

About

Brett Jepson is a scholar working on Pulmonary and Respiratory Medicine, Dermatology and Physiology. According to data from OpenAlex, Brett Jepson has authored 18 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Dermatology and 4 papers in Physiology. Recurrent topics in Brett Jepson's work include Dermatology and Skin Diseases (5 papers), Allergic Rhinitis and Sensitization (4 papers) and Vasculitis and related conditions (4 papers). Brett Jepson is often cited by papers focused on Dermatology and Skin Diseases (5 papers), Allergic Rhinitis and Sensitization (4 papers) and Vasculitis and related conditions (4 papers). Brett Jepson collaborates with scholars based in United States, Sweden and Australia. Brett Jepson's co-authors include Gloria L. David, Donald Y.M. Leung, Patricia A. Taylor, Agustin Calatroni, Anna M. Butcher, Richard L. Gallo, Faiza Shafiq, Amanda K. Rudman Spergel, Keli Johnson and J Cheng and has published in prestigious journals such as Nature Medicine, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Brett Jepson

18 papers receiving 529 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial

2021 205 citations Teruaki Nakatsuji, Tissa Hata et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brett Jepson United States	6	288	193	122	109	77	18	537
Annette Leimgruber Switzerland	13	83 0.3×	270 1.4×	34 0.3×	200 1.8×	51 0.7×	47	529
Stephan Nobbe Switzerland	11	242 0.8×	108 0.6×	32 0.3×	82 0.8×	34 0.4×	23	503
Fernando Specchia Italy	13	161 0.6×	138 0.7×	26 0.2×	72 0.7×	75 1.0×	18	414
M. Rodríguez‐Serna Spain	11	239 0.8×	74 0.4×	34 0.3×	39 0.4×	54 0.7×	47	434
Masato Kakeda Japan	13	316 1.1×	68 0.4×	29 0.2×	71 0.7×	144 1.9×	22	686
Chun Wei Li China	14	55 0.2×	143 0.7×	111 0.9×	184 1.7×	152 2.0×	21	582
Diana Deleanu Romania	12	107 0.4×	125 0.6×	48 0.4×	84 0.8×	44 0.6×	47	457
Irena Krčmová Czechia	11	102 0.4×	157 0.8×	75 0.6×	135 1.2×	21 0.3×	41	363
T Lobera Spain	12	191 0.7×	241 1.2×	40 0.3×	111 1.0×	26 0.3×	29	560
Catherine J.M. Stephens United Kingdom	16	417 1.4×	93 0.5×	35 0.3×	20 0.2×	27 0.4×	30	741

Countries citing papers authored by Brett Jepson

Since Specialization

Citations

This map shows the geographic impact of Brett Jepson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Jepson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Jepson more than expected).

Fields of papers citing papers by Brett Jepson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Jepson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Jepson. The network helps show where Brett Jepson may publish in the future.

Co-authorship network of co-authors of Brett Jepson

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Jepson. A scholar is included among the top collaborators of Brett Jepson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Jepson. Brett Jepson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Panettieri, Reynold A., Njira Lugogo, Wendy C. Moore, et al.. (2023). Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE. Respiratory Medicine. 216. 107285–107285. 4 indexed citations

Schwartz, Michael D., Robert Raulli, WILLIAM B. COLEY, et al.. (2022). Systemic Bioavailability of Sublingual Atropine Ophthalmic Solution: a Phase I Study in Healthy Volunteers with Implications for Use as a Contingency Medical Countermeasure. Journal of Medical Toxicology. 18(3). 187–197. 3 indexed citations

Cohen, Taylor S., Elizabeth J. Kelly, Sven Nylander, et al.. (2022). Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination. Scientific Reports. 12(1). 7961–7961. 5 indexed citations

Nakatsuji, Teruaki, Tissa Hata, Yun Tong, et al.. (2021). Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nature Medicine. 27(4). 700–709. 205 indexed citations breakdown →

McCauley, Kathryn, Kaitlin J. Flynn, Douglas Fadrosh, et al.. (2021). Upper Airway Microbiota Relates to Season and Asthma Exacerbations. Journal of Allergy and Clinical Immunology. 147(2). AB52–AB52. 1 indexed citations

Sobieszczyk, Magdalena E., Ann R. Falsey, Merlin L. Robb, et al.. (2021). LB6. Asymptomatic Infection and Duration of Viral Shedding in Symptomatic Breakthrough Infections in a Phase 3 Study of AZD1222 (ChAdOx1 nCoV-19). Open Forum Infectious Diseases. 8(Supplement_1). S804–S804. 1 indexed citations

Wolfe, Daniel, Eric M. Espeland, Yonghong Gao, et al.. (2020). Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older. Vaccine. 38(50). 7970–7976. 8 indexed citations

Jalbert, Emilie, Stephanie Lussier, Michael Johnson, et al.. (2020). Lower influenza-specific cell-mediated immune responses in individuals with atopic dermatitis compared with healthy controls. Human Vaccines & Immunotherapeutics. 16(11). 2727–2735. 3 indexed citations

Weir, Gordon C., Mario R. Ehlers, Kristina M. Harris, et al.. (2018). Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. Pediatric Diabetes. 19(5). 945–954. 23 indexed citations

10.

Simpson, Eric L., Miguel Villarreal, Brett Jepson, et al.. (2018). Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. Journal of Investigative Dermatology. 138(10). 2224–2233. 139 indexed citations

11.

Leung, Donald Y.M., Brett Jepson, Lisa A. Beck, et al.. (2017). A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology. 139(5). 1575–1582.e8. 11 indexed citations

12.

Geetha, Duvuru, Ulrich Specks, John H. Stone, et al.. (2014). Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement. Journal of the American Society of Nephrology. 26(4). 976–985. 123 indexed citations

13.

Leung, Donald Y.M., Lisa A. Beck, Jon M. Hanifin, et al.. (2014). A Randomized, Multi-Center, NIH/NIAID Funded Study To Assess The Immunogenicity Of Fluzone® Intradermal and Intramuscular Vaccines In Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 133(2). AB72–AB72. 2 indexed citations

14.

Miloslavsky, Eli M., Ulrich Specks, Peter A. Margolis, et al.. (2013). Efficacy Of Glucocorticoids To Treat Limited Flares In ANCA-Associated Vasculitis. Data Archiving and Networked Services (DANS). 1 indexed citations

15.

Miloslavsky, Eli M., Ulrich Specks, Peter A. Merkel, et al.. (2013). Safety Of Remission Induction With Rituximab Versus Cyclosphosphamide In Patients 65 and Older With Severe ANCA-Associated Vasculitis. Data Archiving and Networked Services (DANS). 65. 1 indexed citations

16.

Miloslavsky, Eli M., Ulrich Specks, Peter A. Merkel, et al.. (2013). Retreatment With Rituximab In The Rituximab In ANCA-Associated Vasculitis (RAVE) Trial. Data Archiving and Networked Services (DANS). 65. 1 indexed citations

17.

Miloslavsky, Eli M., Ulrich Specks, Peter A. Merkel, et al.. (2013). Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis. La Presse Médicale. 42(4). 779–780. 2 indexed citations

18.

Miloslavsky, Eli M., Ulrich Specks, Philip Seo, et al.. (2013). Retreatment with Rituximab in the RAVE Trial. La Presse Médicale. 42(4). 778–778. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact